- Report
- October 2025
- 189 Pages
Global
From €3118EUR$3,545USD£2,718GBP
€3464EUR$3,939USD£3,019GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1055EUR$1,200USD£920GBP
€1319EUR$1,500USD£1,150GBP
- Report
- October 2025
- 250 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- March 2025
- 200 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- February 2024
- 70 Pages
India
From €4177EUR$4,750USD£3,641GBP
- Report
- May 2024
- 139 Pages
Global
From €4858EUR$5,524USD£4,235GBP
€5715EUR$6,499USD£4,982GBP
- Report
- November 2020
- 225 Pages
Global
From €13187EUR$14,995USD£11,495GBP
- Report
- December 2025
- 50 Pages
Global
From €2330EUR$2,650USD£2,031GBP
Bromocriptine is a drug used to treat endocrine and metabolic disorders. It is a dopamine agonist, meaning it works by activating dopamine receptors in the body. It is used to treat conditions such as acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders. Bromocriptine is available in both oral and injectable forms.
Bromocriptine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including acromegaly, hyperprolactinemia, and type 2 diabetes. It is also used to treat Parkinson's disease and other neurological disorders.
Some companies in the Bromocriptine market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more
